OOIR: Observatory of International Research

Papers

(The TQCC of Personalized Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward	58
Pharmacogenomics education in China and the United States: advancing personalized medicine	29
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls	20
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis	17
An evidence gap map of the personalized medicine in bladder cancer	15
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients	14
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population	14
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness	12
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension	12
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing	9
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer	8
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?	8
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease	8
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites	8
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis	8
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia	8
Personalized approach in arrhythmology by genetic-based data: a case report	8
Precision acute medical care through “-omic” analyses: a scoping review	8
Prevalence of Protective Haplotypes of the SLCO1B1 Gene for Statin Transport in Mexican Populations	8
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study	7
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?	7
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children	7
Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models	7
Omics Technologies in Personalized Combination Therapy for Cardiovascular Diseases: Challenges and Opportunities	6
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups	6

Welcome to the 19th Volume of Personalized Medicine	6
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation	6
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar	6
Role of precision nutrition in improving military performance	6
Regional disparities in access to gene therapies in the European Union, the United States, Japan, and China	5
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population	5
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam	5
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head	5
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK	5
Looking Back Over 2023 and Welcome to the 21 ^st Issue of Personalized Medicine	5
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice	5
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System	5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries	5
Development of Competency-based Online Genomic Medicine Training (COGENT)	5
Genomics and the early diagnosis of lung cancer	4
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine	4
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment	4
Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan	4
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation	4
The Use of Molecular Biomarker Tests: An Interview Study with Healthcare Providers about a Molecular Biomarker Test for Prostate Cancer	4
Clinical Significance of Serum miR-101-3p Expression in Patients with Neonatal Sepsis	4
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus	4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation	4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device	4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead	4
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines	4